Sphingoid bases in infant formulas

Food Chemistry

Volumn 103, Issue 1, 2007, Pages 173-180

  Ribar, Slavica ^a   Feher Turković, Lana ^a   Karmelić, Ivana ^a   Mesarić, Marko ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

HPLC; Human milk; Infant formulas; Sphinganine; Sphingosine

Indexed keywords

SPHINGANINE; SPHINGOID BASE; SPHINGOLIPID; SPHINGOSINE; UNCLASSIFIED DRUG;

ARTICLE; ARTIFICIAL MILK; CHEMICAL COMPOSITION; CHEMICAL STRUCTURE; EUKARYOTE; FATTY ACID ANALYSIS; FOOD QUALITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROLYSIS; NONHUMAN; STRUCTURE ACTIVITY RELATION;

EUKARYOTA; MAMMALIA; SPHINGOIDEA;

EID: 33847057260     PISSN: 03088146     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.foodchem.2006.07.069     Document Type: Article

References (40)

1. Baumruker T., and Prieschl E.E. Sphingolipids and the regulation of the immune response. Seminars in Immunology 14 (2002) 57-63
2. Bouhours J.F., and Bouhours D. Ceramide structure of sphingomyelin from human milk fat globule membrane. Lipids 16 (1981) 726-731
3. Bourre J.M., Paternau-Jouas M.Y., Daudu O.L., and Baumann N.A. Lignoceric acid biosynthesis in the developing brain. Activities of mitochondrial acetyl-CoA-dependent synthesis and microsomal malonyl-CoA chain-elongating system in relation to myelination. Comparison between normal mouse and dysmyelinating mutants (quaking and jimpy). European Journal of Biochemistry 72 (1977) 41-47
4. Cabot M.C., Giuliano A.E., Han T.Y., and Liu Y.Y. SDZ PSC 833, the cyclosporine A analogue and multidrug resistance modulator, activates ceramide synthesis and increases vinblastine sensitivity in drug-sensitive and drug-resistant cancer cells. Cancer Research 59 4 (1999) 880-885
5. Castegnaro M., Garren L., Galendo D., Gelderblom W.C., Chelule P., Dutton M.F., et al. Analytical method for the determination of sphinganine and sphingosine in serum as a potential biomarker for fumonisin exposure. Journal of Chromatography. B, Biomedical Sciences and Applications 720 1-2 (1998) 15-24
6. Charles A.G., Han T.Y., Liu Y.Y., Hansen N., Giuliano A.E., and Cabot M.C. Taxol-induced ceramide generation and apoptosis in human breast cancer cells. Cancer Chemotherapy and Pharmacology 47 5 (2001) 444-450
7. Davis M.A., Flaws J.A., Young M., Collins K., and Colburn N.H. Effect of ceramide in intracellular glutathione determines apoptotic or necrotic cell death of JB6 tumor cells. Toxicological Sciences 53 1 (2000) 48-55
8. Dillehay D.L., Webb S.K., Schmelz E.M., and Merrill A.H. Dietary sphingomyelin inhibits 1,2-dimethylhydrazine-induced colon cancer in CF1 mice. The Journal of Nutrition 124 (1994) 615-620
9. Furuja K., Ginis I., Takeda H., Chen Y., and Hallenbeck J.M. Cell permeable exogenous ceramide reduces infarct size in spontaneously hypertensive rats supporting in vitro studies that have implicated ceramide in induction of tolerance to ischemia. Journal of Cerebral Blood Flow and Metabolism 21 3 (2001) 226-232
10. Goldman A.S., and Garza C. Future research in human milk. Pediatric Research 22 (1987) 493-496
11. Haimovitz-Friedman A., Kan C.C., Ehleiter D., Persaud R.S., McLoughin M., Fuks Z., et al. Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis. The Journal of Experimental Medicine 180 2 (1994) 525-535
12. Hakomori S. Bifunctional role of glycosphingolipids. Modulators for transmembrane signaling and mediators for cellular interactions. Journal of Biological Chemistry 265 (1990) 18713-18716
13. Ivanković, D., Božikov, J., Kern, J., Kopjar, B., Luković, G., & Vuletić, S. (1991). Principles of statistical analysis for medical students [in Croatian]. Zagreb, Medicinski fakultet Sveučilišta u Zagrebu.
14. Jason J.M., Nieburg P., and Marks J.S. Mortality and infectious disease associated with infant-feeding practices in developing countries. Pediatrics 74 suppl (1984) 702-727
15. Jensen R.G. The lipids in human milk. Progress in Lipid Research 35 (1996) 53-92
16. Jensen R.G., Bitman J., Carlson S.E., Couch S.C., Hamosh M., and Newburg D.S. Human milk lipids. The Handbook of Milk Composition (1995), Academic Press 495-542
17. Koletzko B., Rodriguez-Palmero M., Demmelmair H., Fidler N., Jensen R., and Sauerwald T. Physiological aspects of human milk lipids. Early Human Development 65 Suppl (2001) S3-S18
18. Kovar M.G., Serdula J.S., Marks J.S., and Fraser D.W. Review of the epidemiologic evidence for an association between infant feeding and infant health. Pediatrics 74 suppl (1984) 615-638
19. Laegried A., Otnaess A.B.K., and Fuglesang J. Human and bovine milk: comparison of ganglioside composition and enterotoxin-inhibitory activity. Pediatric Research 20 (1986) 416-421
20. Lucci A., Han T.Y., Liu Y.Y., Giuliano A.E., and Cabot M.C. Modification of ceramide metabolism increases cancer cell sensitivity to cytotoxices. International Journal of Oncology 15 3 (1999) 541-546
21. Maurer B.J., Metelitsa L.S., Seeger R.C., Cabot M.C., and Reynolds C.P. Increase of ceramide and induction of mixed apoptosis/necrosis by N-(4-hydroxyphenyl)-retinamide in neuroblastoma cell lines. Journal of the National Cancer Institute 91 13 (1999) 1138-1146
22. Merrill A.H., Schmelz E.M., Dillehay D.L., Spiegel S., Shayman J.A., Schroeder J.J., et al. Sphingolipids-the enigmatic lipid class: biochemistry, physiology and pathophysiology. Toxicology and Applied Pharmacology 142 (1997) 208-225
23. Merrill A.H., Wang E., Mullins R.E., Charles W., Jamison L., Nimkar S., et al. Quantitation of free sphingosine in liver by high-performance liquid chromatography. Analytical Biochemistry 171 (1988) 373-381
24. Morrison W.R. Polar lipids in bovine milk. I. Long-chain bases in sphingomyelin. Biochimica et Biophysica Acta 176 3 (1969) 537-546
25. Olivera A., and Spiegel S. Ganglioside GM1 and sphingolipid breakdown products in cellular proliferation and signal transduction pathways. Glycoconjgate Journal 9 (1992) 109-117
26. Pan X.L., and Izumi T. Chronological changes in the ganglioside composition of human milk during lactation. Early Human Development 55 (1999) 1-8
27. Ribar S., Mesarić M., and Sedić M. Sphingoid bases as possible diagnostic parameters. Croatian Medical Journal 44 2 (2003) 165-170
28. Riley R.T., Wang E., and Merrill A.H. Liquid chromatographic determination of sphinganine and sphingosine: use of the free sphinganine to sphingosine ration as biomarker for consumption of fumonisins. Journal of AOAC International 77 (1994) 533-540
29. Rueda R., Puente R., Hueso P., Maldonado J., and Gil A. New data on content and distribution of gangliosides in human milk. Biological Chemistry Hoppe-Seyler 376 (1995) 723-727
30. Schmelz E.M., Dillehay D.L., Webb S.K., Reiter A., Adams J., and Merrill A.H. Sphingomyelin consumption suppresses aberrant colonic crypt foci and increases the proportion of adenomas versus adenocarcinomas in CF1 mice treated with 1,2-dimethylhydrazine: implications for dietary sphingolipids and colon carcinogenesis. Cancer Research 56 (1996) 4936-4941
31. Schmelz E.M., Roberts P.C., Kustin E.M., Lemonnier L.A., Sullards M.C., Dillehay D.L., et al. Modulation of intracellular β-catenin localization and intestinal tumorigenesis in vivo and in vitro by sphingolipids. Cancer Research 6 (2001) 6723-6729
32. Schmelz E.M., Sullards M.C., Dillehay D.L., and Merrill Jr. A.H. Colonic cell proliferation and aberrant crypt foci formation are inhibited by dairy glycosphingolipids in 1,2-dimethylhydrazine-treated CF1 mice. The Journal of Nutrition 130 3 (2000) 522-527
33. Solfrizzo M., Avantaggiato G., and Visconti A. Rapid method to determine sphinganine/sphingosine in human and animal urine as a biomarker for fumonisin exposure. Journal of Chromatography B, Biomedical Sciences and Applications 692 1 (1997) 87-93
34. Spiegel S., and Merrill Jr. A.H. Sphingolipid metabolism and cell growth regulation. The FASEB Journal 10 (1996) 1388-1397
35. Spiegel S., and Milstien S. Sphingosine-1-phosphate: signalling inside and out. FEBS Letters 476 1/2 (2000) 55-57
36. Takamizawa K., Iwamori M., Mutai M., and Nagai Y. Selective changes in gangliosides of human milk during lactation: a molecular indicator for the period of lactation. Biochimica et Biophysica Acta 879 (1986) 73-77
37. Van der Westhuizen L., Brown N.L., Marasas W.F., Swanevelder S., and Shephard G.S. Sphinganine/sphingosine ratio in plasma and urine as a possible biomarker for fumonisin exposure in humans in rural areas of Africa. Food and Chemical Toxicology 37 12 (1999) 1153-1158
38. Vesper H., Schmelz E.M., Nikolova-Karakashian M.N., Dillehay D.L., Lynch D.V., and Merrill A.H. Sphingolipids in food and the emerging importance of sphingolipids to nutrition. Journal of Nutrition 129 (1999) 1239-1250
39. Welsh J., and May J.T. Breast milk and infant infection. Medical Journal of Australia 2 (1979) 66-68
40. 1. Toxicology in Vitro 10 (1996) 77-84